thymia

Name: thymia
Brand: thymia

AI Native

The health and safety intelligence layer for all voice communications.

Est 2020|Valuation $26.2M|Raised $11.8M

LinkedIn 6K|Web traffic 15K|FTEs 37|HQ London, England, GB

01Competitive Landscape

Narrative analysis

Potential advantages: - Multimodal approach: The vendor documents combining voice with camera-based movement signals and behavioral activities, which could be beneficial in some use cases. - Integration flexibility: The Activity Plugin provides a hosted capture workflow and the Helios API supports direct recording submission. - Regional endpoints: API base URLs for specific regions are documented, indicating some regional deployment options. Where alternatives may have clearer public evidence: - Some competitors emphasize different tradeoffs, such as a purely voice-only approach or broader public validation narratives. Buyers should review competitor validation and integration documents in detail. Market adoption signals: - Vendor and partner marketing reference healthcare and pharmaceutical engagements, but a comprehensive, independently verified customer list is not consistently published in public materials.

	thymia (Helios / Activity Plugin)	Sonde Health	Kintsugi Voice
Starting Price	Not public	Not public	Not public
Primary Use Cases	Organizations seeking multimodal biomarker capture (voice, camera-derived movement, and behavioral activities); API integration; regional API endpoints documented	Organizations seeking voice-as-a-vital-sign integration for mental, cognitive, or respiratory monitoring	Telehealth and primary care workflows focused on depression/anxiety screening with short-clips and API integration
Key Strength	Vendor describes a multimodal approach and provides both API and hosted activity capture options; regional endpoints are documented	Emphasizes voice-as-vital-sign positioning and SDK/API integration options	Public-facing validation narratives and clinical workflow positioning are emphasized in vendor materials
Key Weakness	Public independent reviews and detailed enterprise security documentation are limited in accessible sources; pricing is opaque	Validation and pricing specifics are often provided via sales channels; independent review corpus is limited	Regulatory and clinical claims require careful validation; vendor materials may describe investigational status

01Competitive Landscape

Narrative analysis

Potential advantages:

Multimodal approach: The vendor documents combining voice with camera-based movement signals and behavioral activities, which could be beneficial in some use cases.
Integration flexibility: The Activity Plugin provides a hosted capture workflow and the Helios API supports direct recording submission.
Regional endpoints: API base URLs for specific regions are documented, indicating some regional deployment options.

Where alternatives may have clearer public evidence:

Some competitors emphasize different tradeoffs, such as a purely voice-only approach or broader public validation narratives. Buyers should review competitor validation and integration documents in detail.

Market adoption signals:

Vendor and partner marketing reference healthcare and pharmaceutical engagements, but a comprehensive, independently verified customer list is not consistently published in public materials.

	thymia (Helios / Activity Plugin)	Sonde Health	Kintsugi Voice
Starting Price	Not public	Not public	Not public
Primary Use Cases	Organizations seeking multimodal biomarker capture (voice, camera-derived movement, and behavioral activities); API integration; regional API endpoints documented	Organizations seeking voice-as-a-vital-sign integration for mental, cognitive, or respiratory monitoring	Telehealth and primary care workflows focused on depression/anxiety screening with short-clips and API integration
Key Strength	Vendor describes a multimodal approach and provides both API and hosted activity capture options; regional endpoints are documented	Emphasizes voice-as-vital-sign positioning and SDK/API integration options	Public-facing validation narratives and clinical workflow positioning are emphasized in vendor materials
Key Weakness	Public independent reviews and detailed enterprise security documentation are limited in accessible sources; pricing is opaque	Validation and pricing specifics are often provided via sales channels; independent review corpus is limited	Regulatory and clinical claims require careful validation; vendor materials may describe investigational status

thymia

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map